MétaCan
Menu
Back to cohort
Record W4409313677 · doi:10.2196/64697

A Deep Learning–Enabled Workflow to Estimate Real-World Progression-Free Survival in Patients With Metastatic Breast Cancer: Study Using Deidentified Electronic Health Records

2025· article· en· W4409313677 on OpenAlexvenueno aff
Gowtham Varma, Rohit K. Yenukoti, Praveen Kumar, Bandlamudi Sai Ashrit, K Purushotham, C Subash, Sunil Kumar Ravi, V.A. Kurien, Avinash Aman, Mithun Manoharan, Shashank Jaiswal, Akash Anand, Rakesh Barve, Viswanathan Thiagarajan, Patrick J. Lenehan, Scott A. Soefje, Venky Soundararajan

Bibliographic record

VenueJMIR Cancer · 2025
Typearticle
Languageen
FieldMedicine
TopicAdvanced Breast Cancer Therapies
Canadian institutionsnot available
Fundersnot available
KeywordsMetastatic breast cancerProgression-free survivalPalbociclibMedicineWorkflowBreast cancerArtificial intelligenceTumor progressionCancerOncologyInternal medicineMachine learningComputer scienceDatabaseOverall survival

Abstract

fetched live from OpenAlex

BACKGROUND: Progression-free survival (PFS) is a crucial endpoint in cancer drug research. The clinician-confirmed cancer progression, namely real-world PFS (rwPFS) in unstructured text (i.e. clinical notes) has been shown to serve as a reasonable surrogate for real-world indicators in ascertaining progression endpoints. Response Evaluation Criteria in Solid Tumors(RECIST) is traditionally used in clinical trials using serial imaging evaluations, which is not practical when working with real-world data. Manual abstraction of clinical progression from unstructured notes continues to be the gold standard. However, this process is a resource-intensive and time-consuming process. Natural Language processing(NLP), a subdomain of machine learning, has shown promise in accelerating the extraction of tumor progression from real world data in recent years. OBJECTIVE: We aim to configure a pre-trained, general-purpose healthcare NLP framework to transform free-text clinical notes and radiology reports into structured progression events for studying rwPFS on metastatic breast cancer (mBC) cohorts. METHODS: This study developed and validated a novel semi-automated workflow to estimate rwPFS in patients with mBC using de-identified EHR data from the nference nSights platform. The developed workflow was validated in a cohort of 316 patients with hormone receptor-positive, human epidermal growth factor receptor 2(HER2)2-negative mBC, who were started on Palbociclib and Letrozole combination therapy between January 2015 and December 2021. Ground-truth datasets were curated to evaluate the workflow's performance at both the sentence and patient levels. NLP-captured progression or a change in therapy line were considered outcome events, while death, loss to follow-up, and end of study period were considered censoring events for rwPFS computation. Peak reduction and cumulative decline in Patient-Health-Questoinnaire-8(PHQ-8) scores were analyzed in the progressed and non-progressed patient subgroups. RESULTS: The configured clinical NLP engine achieved a sentence-level progression capture accuracy of 98.2%. At the patient level, initial progression was captured within ±30 days with 88% accuracy. The median real-world progression-free survival (rwPFS) for the study cohort(N=316) was 20 months (95% CI: 18.0-25.0). In a validation subset(N=100), rwPFS determined by manual curation was 25 months (95% CI: 15-35 months), closely aligning with the computational workflow's 22 months (95% CI: 15-35 months). A sub-analysis revealed rwPFS estimates of 30 months (95% CI: 24.0-39.0) from radiology reports and 23 months (95% CI: 19.0-28.0) from clinical notes, highlighting the importance of integrating multiple note sources. External validation also demonstrated high accuracy (92.5%-sentence-level; 90.2%-patient-level). Sensitivity analysis revealed stable rwPFS estimates across varying levels of missing source data and event definitions. Peak reduction and cumulative decline in PHQ-8 scores during the study period highlighted significant associations between patient-reported outcomes and disease progression. CONCLUSIONS: This workflow enables rapid and reliable determination of rwPFS in mBC patients receiving combination therapy. Further validation across more diverse external datasets and other cancer types is needed to ensure broader applicability and generalizability.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.183
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.003
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.382
Teacher spread0.367 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations6
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJMIR CancerSame topicAdvanced Breast Cancer TherapiesFrench-language works237,207